abrdn Life Sciences Investors (HQL)
NYSE
Fin d'année 30 Septembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -0.876 | -0.762 | -16.287 | 28.251 | 12.674 | -22.047 | 5.47 | 19.763 |
Return on Equity (%) | -0.88 | -0.766 | -16.407 | 28.379 | 12.816 | -22.707 | 5.589 | 19.799 |
Return on Invested Capital (%) | -111.21 | -33.589 | -23.709 | -238.042 | 75.453 | -96.405 | -11.95 | -7.675 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 21.618 | 21.222 | 16.551 | 20.247 | 21.219 | 15.495 | 15.003 | 1.638 |
Earnings Per Share | -0.18 | -0.161 | -3.041 | 5.152 | 2.616 | -4.073 | 0.834 | 0.304 |
Cash Per Share | 0.029 | N/A | 0.048 | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | -0.029 | 0.987 | 0.094 | -0.017 | -0.428 | 0.653 | 0.733 | 0.108 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | 1.373 | 1.432 | -1.583 | 6.592 | 4.273 | -2.642 | 2.08 | 0.465 |
Fin d'année 30 Septembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 21,57M | 22,41M | 23,18M | 23,88M | 24,67M | 25,68M | 26,79M | 280,61M |
Fin d'année 30 Septembre 2024 | ||||||||
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 363,62M |
Ratio cours/bénéfice | 4,28 |
Ratio prix/ventes | 91,68 |
Ratio prix/liquidités | 0 |
Ratio prix/valeur comptable | 0,79 |
Rendement de dividende | 1 168,19% |
Actions en circulation | 25,68M |
Volume moyen (1 semaine) | 86,75k |
Volume moyen (1 mois) | 112,63k |
Variation sur 52 semaines | 3,12% |
Plus haut sur 52 semaines | 15,8999 |
Plus bas sur 52 semaines | 12,76 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales